Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China
· Delayed Price · Currency is CNY 31.77
-0.12 (-0.38%)
At close: Apr 25, 2025, 2:57 PM CST
SHA:688139 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 25, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Market Capitalization | 10,041 | 11,112 | 12,824 | 20,078 | 28,796 | 20,702 | Upgrade
|
| Market Cap Growth | -13.35% | -13.35% | -36.13% | -30.28% | 39.10% | 126.07% | Upgrade
|
| Enterprise Value | 8,533 | 9,530 | 10,935 | 17,327 | 25,931 | 18,996 | Upgrade
|
| Last Close Price | 31.93 | 35.20 | 39.99 | 61.97 | 88.31 | 63.24 | Upgrade
|
| PE Ratio | 27.53 | 30.31 | 31.58 | 33.42 | 34.08 | 54.34 | Upgrade
|
| Forward PE | 23.08 | 17.53 | 18.53 | 25.87 | 39.80 | 50.27 | Upgrade
|
| PS Ratio | 4.40 | 4.87 | 5.62 | 7.01 | 13.55 | 14.77 | Upgrade
|
| PB Ratio | 2.17 | 2.41 | 2.89 | 4.84 | 7.91 | 7.44 | Upgrade
|
| P/TBV Ratio | 3.13 | 3.46 | 3.98 | 6.17 | 9.42 | 9.25 | Upgrade
|
| P/FCF Ratio | 60.87 | 67.36 | 177.91 | 59.37 | 74.39 | 34.07 | Upgrade
|
| P/OCF Ratio | 34.43 | 38.10 | 51.45 | 31.75 | 48.66 | 29.72 | Upgrade
|
| EV/Sales Ratio | 3.74 | 4.17 | 4.79 | 6.05 | 12.20 | 13.55 | Upgrade
|
| EV/EBITDA Ratio | 20.52 | 23.17 | 26.63 | 27.65 | 52.80 | 58.29 | Upgrade
|
| EV/EBIT Ratio | 27.83 | 31.08 | 34.94 | 30.69 | 58.67 | 62.69 | Upgrade
|
| EV/FCF Ratio | 51.72 | 57.77 | 151.70 | 51.24 | 66.99 | 31.26 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.06 | 0.06 | 0.04 | 0.04 | 0.01 | 0.08 | Upgrade
|
| Debt / FCF Ratio | 0.14 | 0.14 | 0.25 | 0.08 | 0.02 | 0.04 | Upgrade
|
| Asset Turnover | 0.40 | 0.40 | 0.41 | 0.55 | 0.48 | 0.40 | Upgrade
|
| Inventory Turnover | 4.09 | 4.09 | 4.53 | 4.84 | 3.58 | 3.93 | Upgrade
|
| Quick Ratio | 2.09 | 2.09 | 2.27 | 2.68 | 2.69 | 2.36 | Upgrade
|
| Current Ratio | 2.59 | 2.59 | 2.69 | 2.95 | 3.02 | 2.62 | Upgrade
|
| Return on Equity (ROE) | 8.41% | 8.41% | 9.60% | 15.72% | 26.44% | 14.65% | Upgrade
|
| Return on Assets (ROA) | 3.39% | 3.39% | 3.55% | 6.79% | 6.25% | 5.42% | Upgrade
|
| Return on Capital (ROIC) | 4.21% | 4.21% | 4.53% | 9.03% | 8.56% | 7.19% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.40% | 6.40% | 6.80% | 13.10% | 11.80% | 10.50% | Upgrade
|
| Earnings Yield | 3.65% | 3.30% | 3.17% | 2.99% | 2.94% | 1.84% | Upgrade
|
| FCF Yield | 1.64% | 1.49% | 0.56% | 1.68% | 1.34% | 2.94% | Upgrade
|
| Dividend Yield | 1.47% | 1.33% | 1.29% | 0.73% | 0.57% | 0.60% | Upgrade
|
| Payout Ratio | 44.48% | 44.48% | 35.16% | 27.04% | 14.30% | 14.98% | Upgrade
|
| Buyback Yield / Dilution | 0.37% | 0.37% | 0.20% | -0.06% | 2.43% | -30.55% | Upgrade
|
| Total Shareholder Return | 1.84% | 1.71% | 1.49% | 0.66% | 3.00% | -29.95% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.